Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Donn
Andrew Donn, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20100298943 | ORTHOPAEDIC JOINT PROSTHESIS IMPLANT KIT - This invention relates to an orthopaedic joint prosthesis implant kit ( | 11-25-2010 |
Günter Donn, Hofheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20080227640 | Plant Growth Regulation - The present invention relates to the use of a compound for plant growth regulation, preferably by application of the compound to plants, to the seeds from which they grow or to the locus in which they grow, in an effective plant growth regulating, preferably non-phytotoxic amount, which compound is an indolinone derivative of formula (I) or an agriculturally acceptable salt thereof: wherein: X is NNHR | 09-18-2008 |
| 20080269055 | Plant Growth Regulation - The present invention relates to a new class of plant growth regulators. In particular, the invention relates to fused azepinone derivative of general formula (I) or an agriculturally acceptable salt thereof wherein X is CO | 10-30-2008 |
| 20100152044 | Plant growth regulation - The present invention relates to the use of a compound for plant growth regulation, preferably by application of the compound to plants, to the seeds from which they grow or to the locus in which they grow, in an effective plant growth regulating, preferably non-phytotoxic amount, which compound is a 3,4-disubstituted maleimide derivative of formula (I) or an agriculturally acceptable salt thereof, wherein: X is aryl or heteroaryl which groups are unsubstituted or substituted; Y is NH or a covalent bond; and Z is aryl or heteroaryl which groups are unsubstituted or substituted and a method for treatment of plants with such compounds in order to induce growth regulating responses. | 06-17-2010 |
Günter Donn, Hofheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20100152044 | Plant growth regulation - The present invention relates to the use of a compound for plant growth regulation, preferably by application of the compound to plants, to the seeds from which they grow or to the locus in which they grow, in an effective plant growth regulating, preferably non-phytotoxic amount, which compound is a 3,4-disubstituted maleimide derivative of formula (I) or an agriculturally acceptable salt thereof, wherein: X is aryl or heteroaryl which groups are unsubstituted or substituted; Y is NH or a covalent bond; and Z is aryl or heteroaryl which groups are unsubstituted or substituted and a method for treatment of plants with such compounds in order to induce growth regulating responses. | 06-17-2010 |
Michael Ray Donn, Concord, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110084030 | METHOD AND SYSTEM FOR MONITORING AND/OR TRACKING SODIUM HYPOCHLORITE USE - A method of monitoring sodium hypochlorite usage, which includes providing a chemical system comprising: a tank of known capacity mounted upon a scale, the scale being capable of generating a series of signals related to the weight of the tank when empty and at various levels of fill; and a system controller for receiving the series of signals from the scale relating to the weight of the tank when empty and at various levels of fill; inputting into the system controller the series of signals from the scale relating to the weight of the tank when empty and at various levels of fill with sodium hypochlorite; inputting into the system controller a concentration of the sodium hypochlorite upon filling of the tank; tracking an age of the sodium hypochlorite within the tank to obtain a percent concentrate of sodium hypochlorite; and displaying usage of sodium hypochlorite on a display. | 04-14-2011 |
Rosy S. Donn, Saratoga, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080260832 | SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION - Biocompatible intraocular microspheres and implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or to prevent the occurrence of one or more ocular conditions, to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like, to enhance normal retinal function and/or to lower intraocular pressure. | 10-23-2008 |
| 20080299178 | SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION - Biocompatible intraocular microspheres and implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or to prevent the occurrence of one or more ocular conditions, to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like, to enhance normal retinal function and/or to lower intraocular pressure. | 12-04-2008 |
Rosy Sheng Donn, Saratoga, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110251201 | Sustained release intraocular implants and methods for preventing retinal dysfunction - Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to prevent the occurrence of one or more ocular conditions, or to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like. | 10-13-2011 |